Current Environment:

Neuroendocrinology Program | Overview

The Neuroendocrinology Program offers comprehensive diagnosis and treatment of endocrine disorders related to hypothalamic and pituitary region tumors, as well as the endocrine late effects of the treatments of other malignancies, hematologic disorders, and neurofibromatosis-1. We work closely with clinicians from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, our Neurofibromatosis Program, our Department of Urology, and our Division of Adolescent/Young Adult Medicine, as well as from the Type 2 Diabetes Mellitus and Thyroid Nodule Programs within the Division of Endocrinology, to provide comprehensive multidisciplinary care. An additional interest of the program is in growth hormone deficiency.

Reaching new heights

Fifteen-year-old twins Peter and Nicholas Campbell are short. As freshmen in high school, they stood at 4 feet 2 inches each. But with a mother who is 5 feet 5 inches, a father who is 5 feet 8 inches, and no additional underlying conditions that might affect their growth, the reason for their below-average height was unknown.

Laurie Cohen, MD, diagnosed the boys with idiopathic short stature (ISS), a condition in which a child doesn't grow to a height that is within the normal range, despite physical makeup and laboratory tests being normal.

Read more of Peter and Nicholas' story.